Synaffix is a biotech company with a clinical-stage platform technology that enables best-in-class antibody-drug conjugates (ADCs), bispecific antibodies and other targeted therapeutics under a technology out-licensing business model. Synaffix was fully acquired by Lonza in June 2023. Aimed at enabling innovative medicines for patients in areas of high unmet medical need, Synaffix has forged a growing number of collaborations with top tier biotech and pharma companies by enabling best-in-class therapeutic candidates for their pipelines.

Prime objective of the R&D group at Synaffix (Lonza Oss) is to provide best-in-class targeted delivery technologies, i.e. development of protein conjugation technologies, linkers and payloads. General focus is on cytotoxic ADCs, however other modalities are also being pursued, such as immuno-oncology, targeted gene therapy, neuromuscular disease. A junior/senior scientist will play a key role in realizing and/or giving direction to Synaffix’ R&D agenda. Depending on the candidate's experience, this position may be designated as either a Scientist or Senior Scientist role"

Job description